about
Identification of somatic mutations in EGFR/KRAS/ALK-negative lung adenocarcinoma in never-smokersPhase II study of camtobell inj. (belotecan) in combination with cisplatin in patients with previously untreated, extensive stage small cell lung cancer.Identification of a radiosensitivity signature using integrative metaanalysis of published microarray data for NCI-60 cancer cells.microDuMIP: target-enrichment technique for microarray-based duplex molecular inversion probes.Exome sequencing reveals recurrent REV3L mutations in cisplatin-resistant squamous cell carcinoma of head and neck.Factors associated with diabetic retinopathy and nephropathy screening in Korea: the Third and Fourth Korea National Health and Nutrition Examination Survey (KNHANES III and IV)Personalized therapy on the horizon for squamous cell carcinoma of the lung.Extracellular Vesicles in Cancer: Cell-to-Cell Mediators of Metastasis.Novel COCH p.V123E Mutation, Causative of DFNA9 Sensorineural Hearing Loss and Vestibular Disorder, Shows Impaired Cochlin Post-Translational Cleavage and Secretion.Phase II clinical and exploratory biomarker study of dacomitinib in patients with recurrent and/or metastatic squamous cell carcinoma of head and neck.Identification of distinct nanoparticles and subsets of extracellular vesicles by asymmetric flow field-flow fractionation.Unshielding Exosomal RNA Unleashes Tumor Growth And Metastasis.MET in gastric cancer with liver metastasis: The relationship between MET amplification and Met overexpression in primary stomach tumors and liver metastasisComplex polymorphisms in endocytosis genes suggest alpha-cyclodextrin as a treatment for breast cancer
P50
Q28383535-2E826ADC-BFF4-4591-9B5A-16635EB05A15Q33406534-C1316853-6032-4663-BEFA-9C0407D1E5F8Q34356765-7FF93E9D-1828-4628-9CDD-7F37669385AEQ35171517-B60E68CB-9E10-4F01-AEAA-17947B25D6A6Q36500914-7AC1A5A3-8503-45B0-9E00-930D2A38D3A9Q36917131-03A6B969-BA35-49E1-9956-2DB854A9D321Q38089287-E0844A18-6FCC-453A-97F6-79A9E2B79198Q38783439-7B9E84F6-001F-4503-898D-2C11A0321B0BQ38845134-21456A8D-B940-43C8-8860-CE8F0009E54BQ48447176-342D2363-1111-44CD-B682-90DD6C6F2171Q49829985-3FDC89D4-0AD6-48E3-8994-51A5DDCFFEC9Q50432615-AC64BF88-36FA-4C27-BFB7-FF208C8368C7Q88780568-97B42213-6CC8-4D5A-80DC-D8A8E9B87AD1Q89387405-C4479672-EEC7-4913-A4FC-0F90C66EB21E
P50
description
researcher ORCID ID = 0000-0002-6504-9927
@en
wetenschapper
@nl
name
Han Sang Kim
@ast
Han Sang Kim
@en
Han Sang Kim
@es
Han Sang Kim
@nl
type
label
Han Sang Kim
@ast
Han Sang Kim
@en
Han Sang Kim
@es
Han Sang Kim
@nl
prefLabel
Han Sang Kim
@ast
Han Sang Kim
@en
Han Sang Kim
@es
Han Sang Kim
@nl
P106
P31
P496
0000-0002-6504-9927